Author

Tamara Matysiak-Budnik

Advances in medical management of gastric cancer
Advances in medical management of gastric cancer

Tamara Matysiak-Budnik

What is the best treatment in 2020?
What is the best treatment in 2020?

Tamara Matysiak-Budnik

Medical therapy for locally advanced cancer
Medical therapy for locally advanced cancer

Tamara Matysiak-Budnik

ADHESION OF GASTRIC CANCER CELLS TO THE ENTERIC NERVOUS SYSTEM IN A NEWLY DEVELOPED CO-CULTURE MODEL: COMPARISON BETWEEN THE INTESTINAL AND DIFFUSE TYPE OF GASTRIC CANCER
ADHESION OF GASTRIC CANCER CELLS TO THE ENTERIC NERVOUS SYSTEM IN A NEWLY DEVELOPED CO-CULTURE MODEL: COMPARISON BETWEEN THE INTESTINAL AND DIFFUSE TYPE OF GASTRIC CANCER

Tamara Matysiak-Budnik  et al.

Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacterand Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portu
Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacterand Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portu

Tamara Matysiak-Budnik  et al.

SERUM PEPSINOGEN LEVELS IN PATIENTS WITH DIFFERENT TYPES OF ATROPHIC GASTRITIS MEASURED BY ELISA AND CHEMILUMINESCENT IMMUNOASSAY
SERUM PEPSINOGEN LEVELS IN PATIENTS WITH DIFFERENT TYPES OF ATROPHIC GASTRITIS MEASURED BY ELISA AND CHEMILUMINESCENT IMMUNOASSAY

Tamara Matysiak-Budnik  et al.

SERUM PEPSINOGENS COMBINED WITH NEW BIOMARKERS MEASURED BY CHEMILUMINESCENT ENZYME IMMUNOASSAY FOR NON-INVASIVE DIAGNOSIS OF ATROPHIC GASTRITIS: A PROSPECTIVE MULTICENTER STUDY
SERUM PEPSINOGENS COMBINED WITH NEW BIOMARKERS MEASURED BY CHEMILUMINESCENT ENZYME IMMUNOASSAY FOR NON-INVASIVE DIAGNOSIS OF ATROPHIC GASTRITIS: A PROSPECTIVE MULTICENTER STUDY

Tamara Matysiak-Budnik  et al.

Item 1 - 7 / 7
1